Wells Fargo analyst Jim Birchenough reiterated an Overweight rating and $56.00 price target on Zymeworks (NYSE: ZYME) claiming that the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE